Clinical Genetics · 2013 · 11 citations · 17 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsNeurogeneticsCopy Number Variant AnalysisCopy Number VariantsGenetic DisordersGenetic SyndromesMendelian Neurological DisordersNeurogenetic DisordersComplex Chromosome RearrangementsDeletionsGene Dosage DisordersGene Duplication DisordersLeukodystrophy GeneticsMultiplex Ligation-dependent Probe AmplificationPelizaeus-merzbacher DiseasePoint Mutations
Pelizaeus-Merzbacher disease (PMD) is caused in most cases by either duplications or point mutations in the PLP1 gene. This disease, a dysmyelinating disorder affecting mainly the central nervous system, has a wide clinical spectrum and its causing mutations act through different molecular mechanisms. Eighty-eight male patients with leukodystrophy were studied. PLP1 gene analysis was performed by the Multiplex Ligation-dependent Probe Amplification technique and DNA sequencing, and, in duplicated cases of PLP1, gene dosage was completed by using array-CGH. We have identified 21 patients with mutations in the PLP1 gene, including duplications, short and large deletions and several point mutations in our cohort. A customized array-CGH at the Xq22.2 area identified several complex rearrangements within the PLP1 gene region. Mutations found in the PLP1 gene are the cause of PMD in around 20% of the patients in this series.
17
Ken Inoue, Hitoshi Osaka, Virginia C. Thurston et al. · The American Journal of Human Genetics · 2002 · 160 citations · Full text
Proteolipid Protein Is Necessary in Peripheral as Well as Central Myelin
James Garbern, Franca Cambi, Xue-Ming Tang et al. · Neuron · 1997 · 154 citations · Full text